Oral Polio Vaccine to Protect Against COVID-19: Out of the Box Strategies?
Date
2021-07-09Journal
Open Forum Infectious DiseasesPublisher
Oxford University PressType
Article
Metadata
Show full item recordAbstract
The global coronavirus disease 2019 pandemic has raised significant concerns of developing rapid, broad strategies to protect the vulnerable population and prevent morbidity and mortality. However, even with an aggressive approach, controlling the pandemic has been challenging, with concerns of emerging variants that likely escape vaccines, nonadherence of social distancing/preventive measures by the public, and challenges in rapid implementation of a global vaccination program that involves mass production, distribution, and execution. In this review, we revisit the utilization of attenuated vaccinations, such as the oral polio vaccine, which are safe, easy to administer, and likely provide cross-protection against respiratory pathogens. We discuss the rationale and data supporting its use and detail description of available vaccines that could be repurposed for curtailing the pandemic.Rights/Terms
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.Identifier to cite or link to this item
http://hdl.handle.net/10713/16392ae974a485f413a2113503eed53cd6c53
10.1093/ofid/ofab367
Scopus Count
Related articles
- Shooting at a Moving Target-Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development.
- Authors: Günl F, Mecate-Zambrano A, Rehländer S, Hinse S, Ludwig S, Brunotte L
- Issue date: 2021 Sep 22
- COVID-19 vaccines: concerns beyond protective efficacy and safety.
- Authors: Lai CC, Chen IT, Chao CM, Lee PI, Ko WC, Hsueh PR
- Issue date: 2021 Aug
- An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
- Authors: van der Ley PA, Zariri A, van Riet E, Oosterhoff D, Kruiswijk CP
- Issue date: 2021
- Polio endgame: Lessons for the global rotavirus vaccination program.
- Authors: Jiang B, Patel M, Glass RI
- Issue date: 2019 May 21
- Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
- Authors: Reche PA
- Issue date: 2020